Enzo Biochem, Inc. (ENZ)
USD 0.32
(20.97%)
USD 0.32
(20.97%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -26.07 Million USD | -228.54% |
| 2023 | 20.28 Million USD | 189.86% |
| 2022 | -22.57 Million USD | -759.21% |
| 2021 | 3.42 Million USD | 110.11% |
| 2020 | -33.89 Million USD | 65.69% |
| 2019 | -98.78 Million USD | -857.09% |
| 2018 | -10.32 Million USD | -312.18% |
| 2017 | -2.5 Million USD | -105.53% |
| 2016 | 45.28 Million USD | 2081.88% |
| 2015 | -2.28 Million USD | 77.1% |
| 2014 | -9.97 Million USD | 45.29% |
| 2013 | -18.23 Million USD | 53.56% |
| 2012 | -39.26 Million USD | -203.0% |
| 2011 | -12.96 Million USD | 41.71% |
| 2010 | -22.23 Million USD | 5.65% |
| 2009 | -23.56 Million USD | -121.2% |
| 2008 | -10.65 Million USD | 19.66% |
| 2007 | -13.26 Million USD | 15.36% |
| 2006 | -15.66 Million USD | -621.54% |
| 2005 | 3 Million USD | 148.21% |
| 2004 | -6.23 Million USD | -262.11% |
| 2003 | 3.84 Million USD | -44.47% |
| 2002 | 6.92 Million USD | 1.61% |
| 2001 | 6.81 Million USD | 2.84% |
| 2000 | 6.62 Million USD | 1.92% |
| 1999 | 6.5 Million USD | 91.18% |
| 1998 | 3.4 Million USD | 126.67% |
| 1997 | 1.5 Million USD | 119.48% |
| 1996 | -7.7 Million USD | -237.5% |
| 1995 | 5.6 Million USD | 5.66% |
| 1994 | 5.3 Million USD | 176.81% |
| 1993 | -6.9 Million USD | -1050.0% |
| 1992 | -600 Thousand USD | 94.44% |
| 1991 | -10.8 Million USD | -163.41% |
| 1990 | -4.1 Million USD | 0.0% |
| 1989 | -4.1 Million USD | -17.14% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.06 Million USD | 53.73% |
| 2024 Q4 | -13.38 Million USD | -343.08% |
| 2024 Q1 | -6.61 Million USD | -111.52% |
| 2024 Q3 | -3.02 Million USD | 1.34% |
| 2023 FY | 20.28 Million USD | 189.86% |
| 2023 Q4 | 57.43 Million USD | 489.91% |
| 2023 Q1 | -12.42 Million USD | -860.12% |
| 2023 Q2 | -10.65 Million USD | 14.26% |
| 2023 Q3 | -14.72 Million USD | -38.22% |
| 2022 Q1 | -2.31 Million USD | -170.96% |
| 2022 FY | -22.57 Million USD | -759.21% |
| 2022 Q4 | 1.63 Million USD | 118.08% |
| 2022 Q3 | -9.04 Million USD | -240.56% |
| 2022 Q2 | -2.65 Million USD | -14.49% |
| 2021 FY | 3.42 Million USD | 110.11% |
| 2021 Q3 | 2 Million USD | -12.86% |
| 2021 Q4 | 3.26 Million USD | 62.91% |
| 2021 Q1 | 299 Thousand USD | 108.99% |
| 2021 Q2 | 2.3 Million USD | 669.9% |
| 2020 FY | -33.89 Million USD | 65.69% |
| 2020 Q1 | -7.64 Million USD | -41.97% |
| 2020 Q4 | -3.32 Million USD | 66.28% |
| 2020 Q2 | -7.68 Million USD | -0.51% |
| 2020 Q3 | -9.86 Million USD | -28.27% |
| 2019 Q3 | 22.26 Million USD | 364.81% |
| 2019 Q1 | -5.98 Million USD | -3.76% |
| 2019 Q4 | -5.38 Million USD | -124.19% |
| 2019 Q2 | -8.4 Million USD | -40.58% |
| 2019 FY | -98.78 Million USD | -857.09% |
| 2018 Q3 | -3.01 Million USD | -234.74% |
| 2018 Q2 | -901 Thousand USD | -40.78% |
| 2018 Q1 | -640 Thousand USD | -780.85% |
| 2018 FY | -10.32 Million USD | -312.18% |
| 2018 Q4 | -5.76 Million USD | -91.11% |
| 2017 Q4 | 94 Thousand USD | 232.39% |
| 2017 Q3 | -71 Thousand USD | 93.26% |
| 2017 FY | -2.5 Million USD | -105.53% |
| 2017 Q2 | -1.05 Million USD | 28.56% |
| 2017 Q1 | -1.47 Million USD | -104.08% |
| 2016 Q4 | 36.13 Million USD | 1808.51% |
| 2016 Q1 | 4.43 Million USD | -47.48% |
| 2016 Q3 | -2.11 Million USD | -130.96% |
| 2016 FY | 45.28 Million USD | 2081.88% |
| 2016 Q2 | 6.83 Million USD | 54.08% |
| 2015 Q4 | 8.44 Million USD | 390.4% |
| 2015 Q2 | -4.09 Million USD | -9.71% |
| 2015 FY | -2.28 Million USD | 77.1% |
| 2015 Q1 | -3.72 Million USD | -17.67% |
| 2015 Q3 | -2.9 Million USD | 28.94% |
| 2014 FY | -9.97 Million USD | 45.29% |
| 2014 Q1 | -2.78 Million USD | 10.15% |
| 2014 Q2 | -3.56 Million USD | -27.95% |
| 2014 Q3 | -455 Thousand USD | 87.24% |
| 2014 Q4 | -3.16 Million USD | -596.48% |
| 2013 FY | -18.23 Million USD | 53.56% |
| 2013 Q4 | -3.1 Million USD | 46.24% |
| 2013 Q3 | -5.77 Million USD | -1.69% |
| 2013 Q2 | -5.67 Million USD | -53.73% |
| 2013 Q1 | -3.69 Million USD | 86.4% |
| 2012 FY | -39.26 Million USD | -203.0% |
| 2012 Q4 | -27.14 Million USD | -695.75% |
| 2012 Q3 | -3.41 Million USD | 19.19% |
| 2012 Q2 | -4.22 Million USD | 6.07% |
| 2012 Q1 | -4.49 Million USD | -11.71% |
| 2011 Q4 | -4.02 Million USD | -90.66% |
| 2011 FY | -12.96 Million USD | 41.71% |
| 2011 Q3 | -2.11 Million USD | 63.03% |
| 2011 Q2 | -5.7 Million USD | -408.73% |
| 2011 Q1 | -1.12 Million USD | 79.65% |
| 2010 Q4 | -5.51 Million USD | -20.48% |
| 2010 Q3 | -4.57 Million USD | 55.69% |
| 2010 FY | -22.23 Million USD | 5.65% |
| 2010 Q2 | -10.32 Million USD | -469.35% |
| 2010 Q1 | -1.81 Million USD | 65.64% |
| 2009 FY | -23.56 Million USD | -121.2% |
| 2009 Q2 | -7.67 Million USD | -20.46% |
| 2009 Q3 | -4.24 Million USD | 44.72% |
| 2009 Q4 | -5.27 Million USD | -24.45% |
| 2009 Q1 | -6.37 Million USD | -95.46% |
| 2008 Q2 | -4.05 Million USD | -228.98% |
| 2008 Q4 | -3.25 Million USD | -54.6% |
| 2008 FY | -10.65 Million USD | 19.66% |
| 2008 Q1 | -1.23 Million USD | 63.0% |
| 2008 Q3 | -2.1 Million USD | 47.99% |
| 2007 FY | -13.26 Million USD | 15.36% |
| 2007 Q4 | -3.33 Million USD | 13.12% |
| 2007 Q3 | -3.83 Million USD | 21.0% |
| 2007 Q2 | -4.85 Million USD | -289.41% |
| 2007 Q1 | -1.24 Million USD | 72.37% |
| 2006 FY | -15.66 Million USD | -621.54% |
| 2006 Q4 | -4.5 Million USD | -31.23% |
| 2006 Q3 | -3.43 Million USD | 22.6% |
| 2006 Q2 | -4.43 Million USD | -35.09% |
| 2006 Q1 | -3.28 Million USD | -65.04% |
| 2005 Q1 | 7.02 Million USD | 275.85% |
| 2005 FY | 3 Million USD | 148.21% |
| 2005 Q4 | -1.99 Million USD | -33.0% |
| 2005 Q3 | -1.49 Million USD | -183.52% |
| 2005 Q2 | -528 Thousand USD | -107.52% |
| 2004 Q3 | -460 Thousand USD | 68.38% |
| 2004 Q1 | -323 Thousand USD | 87.2% |
| 2004 FY | -6.23 Million USD | -262.11% |
| 2004 Q4 | -3.99 Million USD | -767.96% |
| 2004 Q2 | -1.45 Million USD | -350.46% |
| 2003 Q3 | 1.23 Million USD | -14.73% |
| 2003 Q2 | 1.44 Million USD | -60.79% |
| 2003 Q1 | 3.68 Million USD | 113.82% |
| 2003 Q4 | -2.52 Million USD | -304.62% |
| 2003 FY | 3.84 Million USD | -44.47% |
| 2002 FY | 6.92 Million USD | 1.61% |
| 2002 Q1 | 1.82 Million USD | 6.49% |
| 2002 Q2 | 822 Thousand USD | -54.96% |
| 2002 Q3 | 2.55 Million USD | 210.34% |
| 2002 Q4 | 1.72 Million USD | -32.39% |
| 2001 Q1 | 1.67 Million USD | 5.57% |
| 2001 Q2 | 1.56 Million USD | -6.46% |
| 2001 Q3 | 1.86 Million USD | 18.91% |
| 2001 Q4 | 1.71 Million USD | -7.91% |
| 2001 FY | 6.81 Million USD | 2.84% |
| 2000 Q3 | 2 Million USD | 33.53% |
| 2000 FY | 6.62 Million USD | 1.92% |
| 2000 Q1 | 1.5 Million USD | -46.43% |
| 2000 Q2 | 1.5 Million USD | 0.0% |
| 2000 Q4 | 1.58 Million USD | -20.88% |
| 1999 Q4 | 2.8 Million USD | 64.71% |
| 1999 Q1 | 700 Thousand USD | -50.0% |
| 1999 FY | 6.5 Million USD | 91.18% |
| 1999 Q2 | 1.3 Million USD | 85.71% |
| 1999 Q3 | 1.7 Million USD | 30.77% |
| 1998 Q1 | 500 Thousand USD | -16.67% |
| 1998 Q2 | 600 Thousand USD | 20.0% |
| 1998 FY | 3.4 Million USD | 126.67% |
| 1998 Q4 | 1.4 Million USD | 55.56% |
| 1998 Q3 | 900 Thousand USD | 50.0% |
| 1997 Q4 | 600 Thousand USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | 101.04% |
| 1997 Q2 | 200 Thousand USD | 100.0% |
| 1997 FY | 1.5 Million USD | 119.48% |
| 1997 Q3 | 600 Thousand USD | 200.0% |
| 1996 Q1 | 900 Thousand USD | 106.47% |
| 1996 Q4 | -9.6 Million USD | -2500.0% |
| 1996 Q3 | 400 Thousand USD | -33.33% |
| 1996 Q2 | 600 Thousand USD | -33.33% |
| 1996 FY | -7.7 Million USD | -237.5% |
| 1995 Q4 | -13.9 Million USD | -7050.0% |
| 1995 Q2 | 500 Thousand USD | -97.34% |
| 1995 FY | 5.6 Million USD | 5.66% |
| 1995 Q1 | 18.8 Million USD | 261.54% |
| 1995 Q3 | 200 Thousand USD | -60.0% |
| 1994 Q4 | 5.2 Million USD | 5300.0% |
| 1994 Q3 | -100 Thousand USD | 66.67% |
| 1994 FY | 5.3 Million USD | 176.81% |
| 1994 Q1 | 500 Thousand USD | 0.0% |
| 1994 Q2 | -300 Thousand USD | -160.0% |
| 1993 Q3 | -300 Thousand USD | -400.0% |
| 1993 Q4 | - USD | 100.0% |
| 1993 Q2 | 100 Thousand USD | -75.0% |
| 1993 Q1 | 400 Thousand USD | 133.33% |
| 1993 FY | -6.9 Million USD | -1050.0% |
| 1992 Q1 | -400 Thousand USD | 93.1% |
| 1992 Q4 | -1.2 Million USD | -1300.0% |
| 1992 FY | -600 Thousand USD | 94.44% |
| 1992 Q3 | 100 Thousand USD | 133.33% |
| 1992 Q2 | -300 Thousand USD | 25.0% |
| 1991 Q1 | -1 Million USD | -150.0% |
| 1991 FY | -10.8 Million USD | -163.41% |
| 1991 Q2 | -1.9 Million USD | -90.0% |
| 1991 Q4 | -5.8 Million USD | -176.19% |
| 1991 Q3 | -2.1 Million USD | -10.53% |
| 1990 Q1 | -800 Thousand USD | 0.0% |
| 1990 Q4 | -400 Thousand USD | 71.43% |
| 1990 FY | -4.1 Million USD | 0.0% |
| 1990 Q2 | -1.5 Million USD | -87.5% |
| 1990 Q3 | -1.4 Million USD | 6.67% |
| 1989 FY | -4.1 Million USD | -17.14% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.24 Billion USD | 102.103% |
| Charles River Laboratories International, Inc. | 474.62 Million USD | 105.494% |
| Quest Diagnostics Incorporated | 854 Million USD | 103.054% |
| Danaher Corporation | 4.76 Billion USD | 100.547% |
| IQVIA Holdings Inc. | 1.35 Billion USD | 101.92% |
| Laboratory Corporation of America Holdings | 418 Million USD | 106.239% |
| Mettler-Toledo International Inc. | 788.77 Million USD | 103.306% |
| Qiagen N.V. | 341.3 Million USD | 107.641% |
| Revvity, Inc. | 693.09 Million USD | 103.763% |
| Thermo Fisher Scientific Inc. | 5.99 Billion USD | 100.435% |
| Waters Corporation | 642.23 Million USD | 104.061% |